Orris

Cannabis use a brain atrophy

Reading File
Finding Sources
Searching PubMed

cannabis marijuana brain atrophy gray matter volume

Searching the Web

cannabis brain atrophy neuroimaging evidence 2024 2025

Finding Sources
Finding Sources
Searching PubMed

cannabis brain structure neuroimaging

Finding Sources
Finding Sources
Reading Web Page

https://www.frontiersin.org/journals/psychiatry/articles/10.…

Finding Sources
Searching Images

cannabis marijuana brain MRI gray matter atrophy

This diagnostic comparison chart utilizes Voxel-Based Morphometry (VBM) on brain MRI renderings to illustrate the correlation between BF-227 PET uptake (amyloid-beta deposition) and gray matter atrophy across three clinical groups: Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), and Normal Controls (NC). The visualization presents four views per group: Right Lateral, Left Lateral, Left Medial, and Right Medial. Significant areas of gray matter volume decrease are highlighted with a heat map (red to yellow). In the AD group, extensive atrophy is visible globally, particularly in the lateral temporal gyrus, precuneus, and cingulate cortex. The MCI group shows a similar but less extensive distribution of atrophy, primarily localized to the medial temporal and superior medial surfaces. In the NC group, atrophy is minimal and highly localized, primarily restricted to the posterior medial regions. This progression illustrates the neuroanatomical evolution of Alzheimer’s disease, highlighting the relationship between amyloid deposition and structural brain volume loss in key regions like the precuneus and temporal lobes.

This diagnostic comparison chart utilizes Voxel-Based Morphometry (VBM) on brain MRI renderings to illustrate the correlation between BF-227 PET uptake (amyloid-beta deposition) and gray matter atrophy across three clinical groups: Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), and Normal Controls (NC). The visualization presents four views per group: Right Lateral, Left Lateral, Left Medial, and Right Medial. Significant areas of gray matter volume decrease are highlighted with a heat map (red to yellow). In the AD group, extensive atrophy is visible globally, particularly in the lateral temporal gyrus, precuneus, and cingulate cortex. The MCI group shows a similar but less extensive distribution of atrophy, primarily localized to the medial temporal and superior medial surfaces. In the NC group, atrophy is minimal and highly localized, primarily restricted to the posterior medial regions. This progression illustrates the neuroanatomical evolution of Alzheimer’s disease, highlighting the relationship between amyloid deposition and structural brain volume loss in key regions like the precuneus and temporal lobes.

This diagnostic image is a series of 18 axial MRI brain slices displaying Voxel-Based Morphometry (VBM) results. The slices are arranged sequentially from inferior to superior, with z-axis coordinates labeled from -35 to +50. The background provides anatomical detail in grayscale, while a heat-map overlay (red-to-yellow) highlights areas of statistically significant gray matter atrophy in patients with Cerebral Small Vessel Disease (CSVD) compared to healthy controls. A color-coded t-statistic scale (ranging from 0 to 10) indicates the degree of volume loss, with yellow representing the highest significance (p < 0.0001). Key anatomical regions exhibiting atrophy include the bilateral cerebellum (visible at z = -35 to -25), the right thalamus and inferior frontal gyrus (z = +5 to +15), and the anterior and medial cingulate cortices (z = +25 to +40). This visual serves as a neuroimaging demonstration of structural brain changes associated with CSVD and potential cognitive or autonomic dysfunction.

This diagnostic image is a series of 18 axial MRI brain slices displaying Voxel-Based Morphometry (VBM) results. The slices are arranged sequentially from inferior to superior, with z-axis coordinates labeled from -35 to +50. The background provides anatomical detail in grayscale, while a heat-map overlay (red-to-yellow) highlights areas of statistically significant gray matter atrophy in patients with Cerebral Small Vessel Disease (CSVD) compared to healthy controls. A color-coded t-statistic scale (ranging from 0 to 10) indicates the degree of volume loss, with yellow representing the highest significance (p < 0.0001). Key anatomical regions exhibiting atrophy include the bilateral cerebellum (visible at z = -35 to -25), the right thalamus and inferior frontal gyrus (z = +5 to +15), and the anterior and medial cingulate cortices (z = +25 to +40). This visual serves as a neuroimaging demonstration of structural brain changes associated with CSVD and potential cognitive or autonomic dysfunction.

This diagnostic image displays Voxel-Based Morphometry (VBM) results derived from functional and structural MRI, illustrating gray matter atrophy in patients with Vascular Dementia (VD) compared to those with Vascular Cognitive Impairment No Dementia (VCIND). The left panel consists of a montage of axial brain slices displaying statistically significant areas of atrophy (p < 0.05) highlighted in blue. These blue-shaded regions are primarily concentrated in subcortical structures, including the thalamus and basal ganglia, as well as portions of the cerebellum. The right panel shows three-dimensional cortical surface renderings from lateral, medial, dorsal, and ventral perspectives. These renderings further localize atrophy to the bilateral fusiform gyri, lingual gyri, and inferior temporal regions, with a color scale bar indicating statistical intensity ranging from 2.09 to 6.85. The visualization demonstrates the pattern of progressive neurodegeneration characteristic of vascular cognitive decline, highlighting both deep gray matter and cortical involvement.

This diagnostic image displays Voxel-Based Morphometry (VBM) results derived from functional and structural MRI, illustrating gray matter atrophy in patients with Vascular Dementia (VD) compared to those with Vascular Cognitive Impairment No Dementia (VCIND). The left panel consists of a montage of axial brain slices displaying statistically significant areas of atrophy (p < 0.05) highlighted in blue. These blue-shaded regions are primarily concentrated in subcortical structures, including the thalamus and basal ganglia, as well as portions of the cerebellum. The right panel shows three-dimensional cortical surface renderings from lateral, medial, dorsal, and ventral perspectives. These renderings further localize atrophy to the bilateral fusiform gyri, lingual gyri, and inferior temporal regions, with a color scale bar indicating statistical intensity ranging from 2.09 to 6.85. The visualization demonstrates the pattern of progressive neurodegeneration characteristic of vascular cognitive decline, highlighting both deep gray matter and cortical involvement.

Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Now I have rich, authoritative content from Harrison's Principles (2025) and Kaplan & Sadock, plus the latest neuroimaging evidence from the 2025 Frontiers review and the 2024 Oxford/BMJ Mental Health study. Let me compile a thorough response.

Cannabis Use and Brain Atrophy

Overview

The relationship between cannabis use and structural brain changes is real but nuanced. Neuroimaging studies consistently show morphological differences in cannabis users - particularly reductions in cortical thickness and gray matter volume - but recent large-scale genetic analyses question whether cannabis directly causes these changes.

The Endocannabinoid System: Why the Brain is Vulnerable

THC (D9-tetrahydrocannabinol) acts as a partial agonist at CB1 receptors, which are predominantly expressed on presynaptic axons and nerve terminals throughout the brain. CB1 receptors are densely concentrated in:
  • Prefrontal cortex - executive function, decision-making
  • Hippocampus - memory formation and consolidation
  • Amygdala - emotional processing and stress regulation
  • Basal ganglia / nucleus accumbens - reward and motivation
  • Cerebellum - motor coordination
THC disrupts the normally "just-in-time" endocannabinoid signaling by providing a sustained, dose-dependent stimulus rather than the precise, on-demand modulation of 2-AG and anandamide. This chronic overstimulation is thought to underlie long-term neuroadaptations. - Kaplan & Sadock's Comprehensive Textbook of Psychiatry

Structural Brain Changes: What the Evidence Shows

1. Cortical Thinning

A 2025 scoping review in Frontiers in Psychiatry (Nosko et al.) examined neuroimaging studies in adolescents and young adults. Of 10 sMRI studies examining cortical thickness:
  • 80% (8/10) reported decreased cortical thickness in cannabis users vs. non-using controls
  • Thinning was most consistently found in:
    • Frontal lobes (most replicated finding)
    • Hippocampal cortex
    • Cingulate cortex
Harrison's (2025) cites European research in 799 adolescents showing "a negative, dose-dependent correlation between self-reported cannabis use at age 14 and prefrontal cortex thickness at age 19" - suggesting cannabis during middle-to-late adolescence may directly alter cortical development. - Harrison's Principles of Internal Medicine, 22nd Ed.

2. Gray Matter Volume Reduction

VBM (voxel-based morphometry) studies frequently report reduced gray matter volumes in cannabis users, particularly:
  • Hippocampus - one study found diminished hippocampal gray matter in cannabis users, with possible protective effects from CBD
  • Prefrontal and orbitofrontal cortex
  • Parahippocampal and fusiform gyri
  • Amygdala (findings less consistent)
However, an intriguing 2025 study on middle-aged and older adults (PMC12889878) found larger subcortical volumes in cannabis users compared to non-users, suggesting possible preservation of CB1-dense subcortical structures with aging - though this may reflect selection bias.

3. White Matter Integrity

The Adolescent Brain and Cognitive Development (ABCD) study - a longitudinal neuroimaging cohort of ~12,000 US children - found "small but significant effects on white matter integrity during childhood, especially in the fornix," following prenatal cannabis exposure. The fornix connects hippocampal structures and is integral to memory and emotional processing. - Harrison's Principles of Internal Medicine, 22nd Ed.

4. Functional Connectivity

A 2023 systematic review (Lorenzetti et al., PMID 36563921) found cannabinoids alter resting-state functional brain connectivity. The largest-ever study on cannabis and brain function (January 2025, JAMA Network Open) found:
  • 63% of heavy lifetime cannabis users showed reduced brain activity during working memory tasks
  • 68% of recent users showed a similar impairment

The Critical Causal Question

The biggest challenge in this field is establishing causation vs. association. In October 2024, researchers from Oxford Population Health published the largest observational study to date (BMJ Mental Health, n=15,896 UK Biobank participants):
  • Lifetime cannabis use was associated with structural brain differences and neurocognitive changes
  • However, Mendelian randomization analysis (genetic data) found NO significant causal associations between genetically predicted cannabis use/dependence and neurocognitive decline or brain structure changes
This raises the possibility that:
  1. Pre-existing brain differences predispose individuals to cannabis use (reverse causation)
  2. Confounding factors (socioeconomic status, comorbid substance use, psychiatric conditions) drive the observed differences
  3. The brain changes observed may reflect a complex interaction rather than direct toxicity

Adolescent Brain: The Most Vulnerable Window

The neurodevelopmental period carries unique risk. Harrison's states:
"Children and adolescents are also more vulnerable to the harmful effects of cannabis... Brain imaging studies have revealed that use of cannabis at this stage is associated with structural and functional brain changes... often in the form of reduced brain connectivity and cortical thickness."
Key concerns include:
  • ECS signaling is critical for neuronal migration, synaptogenesis, and connectivity during development
  • Perturbation during fetal or adolescent development can produce lasting structural changes
  • ABCD study data suggest pre-adolescent cannabis exposure correlates with lower episodic, verbal, inhibitory, and working memory task performance

Prenatal Exposure

Prenatal cannabis exposure (now a growing concern given widespread legalization) is associated with:
  • Increased intracranial volumes with blunted visuospatial processing development
  • White matter integrity changes in the fornix
  • Cognitive and memory impairments in offspring
  • The American College of Obstetricians and Gynecologists recommends against cannabis use in pregnancy or when planning pregnancy

Cognitive Consequences of Structural Changes

Brain atrophy in cannabis-relevant regions maps onto observed cognitive deficits. Kaplan & Sadock lists cannabis as a recognized cause of substance/medication-induced neurocognitive disorder, alongside alcohol and cocaine. Key impairments include:
  • Working memory (prefrontal-hippocampal circuit)
  • Verbal memory and learning (hippocampus)
  • Executive function (prefrontal cortex)
  • Episodic memory (hippocampal-fornix circuit)
  • Processing speed (white matter tracts)

Summary Table

Brain RegionStructural ChangeFunctional Impact
Prefrontal cortexCortical thinning (dose-dependent)Executive function, impulse control
HippocampusVolume reduction, cortical thinningMemory formation and retrieval
Cingulate cortexCortical thinningAttention, conflict monitoring
White matter (fornix)Reduced integrityMemory, emotional processing
AmygdalaInconsistent volume changesEmotional regulation

Bottom Line

The evidence for structural brain changes with cannabis use is substantial but not definitively causal for adults. The association is strongest and most concerning for:
  1. Early-onset users (adolescents), where dose-dependent prefrontal thinning is well-documented
  2. Heavy/frequent users, with cumulative effects on hippocampal and cortical volumes
  3. Prenatal exposure, with lasting effects on offspring brain development
The 2024 Oxford genetic analysis adds important nuance - brain differences may not be purely drug-caused, and predisposing vulnerability likely plays a role. Nevertheless, given the dose-dependent cortical thinning in adolescents and white matter disruption, the evidence supports treating the developing brain as particularly at risk.
This is a shared conversation. Sign in to Orris to start your own chat.